1-11 of 11
Massimo Broggini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B170: The in vitro anti-tumor activity of the multi-kinase inhibitor nemtabrutinib (ARQ-531, MK-1026) is seen across multiple B-cell lymphoma subtypes, only partially overlapping with what achieved by single BTK inhibition

Giulio Sartori, Filippo Spriano, Luciano Cascione, Chiara Tarantelli, Alberto J. Arribas, Luca Aresu, Davide Rossi, Giovanna Damia, Massimo Broggini, Francesco Bertoni
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B170.
https://doi.org/10.1158/1535-7163.TARG-23-B170
Published: 01 December 2023
View article titled, Abstract B170: The <em>in vitro</em> anti-tumor activity of the multi-kinase inhibitor nemtabrutinib (ARQ-531, MK-1026) is seen across multiple B-cell lymphoma subtypes, only partially overlapping with what achieved by single BTK inhibition
Journal Articles

Abstract A112: RanBP9 protects cells from genotoxic stress and increased expression is predictive of worse response to platinum in NSCLC patients

Anna Tessari, Kareesma Parbhoo, Meghan Pawlikowski, Matteo Fassan, Eliana Rulli, Claudia Foray, Alessandra Fabbri, Valerio Embrione, Monica Ganzinelli, Marina Capece, Moray J. Campbell, Massimo Broggini, Krista La Perle, Gabriella Farina, Sara Cole, Mirko Marabese, Joseph M. Amann, David P. Carbone, Marina C. Garassino, Carlo M. Croce, Dario Palmieri, Vincenzo Coppola
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A112.
https://doi.org/10.1158/1535-7163.TARG-17-A112
Published: 01 January 2018
View article titled, Abstract A112: RanBP9 protects cells from genotoxic stress and increased expression is predictive of worse response to platinum in NSCLC patients
Journal Articles

Breast Cancer–Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown

Sara Previdi, Giovanni Abbadessa, Francesca Dalò, Dennis S. France, Massimo Broggini
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (1): 214–223.
https://doi.org/10.1158/1535-7163.MCT-11-0277
Published: 09 January 2012
View article titled, Breast Cancer–Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown
Open the PDF for Breast Cancer–Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown in another window
Includes: Supplementary data
Journal Articles

Abstract B77: KRAS mutational status impact progression-free survival of patients treated with platinum-based chemotherapy in NSCLC.

Mirko Marabese, Eliana Rulli, Anna Bettini, Marina C. Garassino, Flavia Longo, Luca Moscetti, Ida Pavese, Calogero Lauricella, Massimo Broggini, Gabriella Farina
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B77.
https://doi.org/10.1158/1535-7163.TARG-11-B77
Published: 12 November 2011
View article titled, Abstract B77: KRAS mutational status impact progression-free survival of patients treated with platinum-based chemotherapy in NSCLC.
Journal Articles

Spectrum of Cellular Responses to Pyriplatin, a Monofunctional Cationic Antineoplastic Platinum(II) Compound, in Human Cancer Cells

Katherine S. Lovejoy, Maria Serova, Ivan Bieche, Shahin Emami, Maurizio D'Incalci, Massimo Broggini, Eugenio Erba, Christian Gespach, Esteban Cvitkovic, Sandrine Faivre, Eric Raymond, Stephen J. Lippard
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (9): 1709–1719.
https://doi.org/10.1158/1535-7163.MCT-11-0250
Published: 07 September 2011
View article titled, Spectrum of Cellular Responses to Pyriplatin, a Monofunctional Cationic Antineoplastic Platinum(II) Compound, in Human Cancer Cells
Open the PDF for Spectrum of Cellular Responses to Pyriplatin, a Monofunctional Cationic Antineoplastic Platinum(II) Compound, in Human Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Nucleotide excision repair (NER) plays a central role in the mechanism of action of nemorubicin: Silencing of XPG as a mechanism of resistance

Maria Sabatino, Cristina Geroni, Laura Capolongo, Luigi Quintieri, Mirko Marabese, Paolo Cappella, Arturo Galvani, Massimo Broggini
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A169.
Published: 01 November 2007
View article titled, Nucleotide excision repair (NER) plays a central role in the mechanism of action of nemorubicin: Silencing of XPG as a mechanism of resistance
Journal Articles

ΔNp63 expression associates with poor survival in ovarian cancer.

Sergio Marchini, Mirko Marabese, Eleonora Marrazzo, Pietro Mariani, Dario Cattaneo, Roldano Fossati, Anna Compagnoni, Robert fruscio, Andrea Alberto Lissoni, Massimo Broggini
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B206.
Published: 01 November 2007
View article titled, ΔNp63 expression associates with poor survival in ovarian cancer.
Journal Articles

Expression levels of different p53 and p73 isoforms in ovarian cancer

Mirko Marabese, Sergio Marchini, Eleonora Marrazzo, Pietro Mariani, Dario Cattaneo, Roldano Fossati, Anna Compagnoni, Mauro Signorelli, Ute Moll, Massimo Broggini
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B207.
Published: 01 November 2007
View article titled, Expression levels of different p53 and p73 isoforms in ovarian cancer
Journal Articles

Antitumor activity of brostallicin on human prostatic cancer: role of combination with hypomethylating agents

Massimo Broggini, Maria Sabatino, Cristina Geroni, Steven Weitman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A288.
Published: 01 November 2007
View article titled, Antitumor activity of brostallicin on human prostatic cancer: role of combination with hypomethylating agents
Journal Articles

Occurrence and mode of the interaction between brostallicin and the human glutathione transferases GSTP1-1 and GSTM2-2

Anna Caccuri, Giorgio Ricci, Silvia Pezzola, Paola Turella, Massimo Broggini, Cristina Geroni, Robert MacArthur
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C249.
Published: 01 November 2007
View article titled, Occurrence and mode of the interaction between brostallicin and the human glutathione transferases GSTP1-1 and GSTM2-2
Journal Articles

Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy

Luigi Manenti, Elena Riccardi, Sergio Marchini, Elitza Naumova, Irene Floriani, Angela Garofalo, Romina Dossi, Eleonora Marrazzo, Domenico Ribatti, Eugenio Scanziani, MariaRosa Bani, Dorina Belotti, Massimo Broggini, Raffaella Giavazzi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (5): 715–725.
https://doi.org/10.1158/1535-7163.MCT-04-0305
Published: 16 May 2005
View article titled, Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy
Open the PDF for Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy in another window